N/A N=103 Smoking Cessation in Alcoholics
Smoking Cessation · Alcohol Consumption
Primary: Number of Smoke-free Patients — 0; 3 participants — p==.111
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=34 Youth Smoking Cessation: Therapy +/- "The Patch"
Smoking
Primary: Acceptance of Nicotine Replacement Therapy — 26 participants
Phase 4 N=1,346 Smoking Cessation Intervention: Effectiveness in Primary Care
Tobacco Dependence
Primary: 6 Month Self-reported Abstinence From Smoking — 50; 52; 45; 75 participants
Phase 4 N=1,504 Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
Nicotine Dependence
Primary: 7-day Point Prevalence of Smoking, Biochemically (Exhaled CO) Confirmed — 90; 87; 107; 84 participants with<10 ppm exhaled CO
N/A N=116 Coping Skills Treatment for Smoking Cessation
Nicotine Dependence
Primary: Number of Participants With Biochemically Verified Smoking Abstinence — 11; 12 Participants
Phase 4 N=30 Tobacco Cessation Treatment Preferences Among Veteran Smokers
Tobacco Use
Primary: Number of Participants Who Report Post-treatment Satisfaction — 15; 10 Participants
N/A N=56 Engaging Patients in Tobacco Cessation Resources in Dental Settings
Smoking
Primary: Percentage of Smokers With Delivery of Brief Interventions and/or Referral to Treatment — 7; 36 Participants
N/A N=19 Smoking Cessation for Smokers With Sleep Problems
Nicotine Dependence · Cigarette Smoking · Insomnia
Primary: Smoking Abstinence — 1; 2; 1; 0 participants
N/A N=154 Enhancing a High School Based Smoking Cessation Program
Nicotine Dependence
Primary: Abstinence Rates at the End of Treatment — 35.1; 24.3; 38.6; 36.1 percentage of participants not smoking
N/A N=51 Health-Kit Enabled Mobile App for Tobacco Cessation
Cigarette Smoking
Primary: Psychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome — 12.7; 13.6 score on a scale — p=0.17
Phase 2 N=38 Treating Smokers With Mental Illness
Smoking Cessation · Cigarette Smoking · Schizophrenia
Primary: 7-Day Point Prevalence Abstinence — 5; 3; 4; 5 Participants
Phase 4 N=1,270 Smoking Cessation in Hospitalized Smokers
Smoking Cessation
Primary: Percentage of Participants With 30-day Abstinence — 18.0; 23.4; 22.1; 18.7 percentage of participants
Phase 1 N=58 Persistence-Targeted Smoking Cessation
Tobacco Use Disorder
Primary: 7-day Point Prevalence Abstinence — 4; 1 participants
N/A N=303 Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial
Smoking Cessation
Primary: Number of Participants With Biochemically Verified 7-day Point Prevalence Tobacco Abstinence at 6 Months — 29; 51 Participants
N/A N=1,094 Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
Smoking Cessation
Primary: Percentage of Patients With 7-day Sustained Smoking Abstinence Reported in the Patient Survey — 13.0; 13.5 percentage of participants — p=0.865
Phase 3 N=750 Disease Management for Smoking Cessation
Smoking Cessation
Primary: 7-day Point Prevalence Abstinence From Cigarettes — 68; 56; 56 Participants — p=0.54
N/A N=225 The Get Quit - Stay Quit Study
Nicotine Dependent Cigarette Smoker
Primary: Number of Participants Reporting no Tobacco Use in the Past 7 Days and Have a Validated CO <10ppm — 61; 55 Participants — p=.65
N/A N=1,298 Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)
Smoking · Smoking Cessation
Primary: Continuous Abstinence — 173; 136 Participants
Phase 4 N=312 Smoking Cessation Study In Healthy Adolescent Smokers
Smoking Cessation
Primary: 4-Week Continuous Abstinence Rate: Percentage of Participants Who Remained Abstinent From Week 9 Through Week 12 — 20.2; 27.2; 18.0 percentage of participants — p=0.6337
Phase 4 N=270 Helping Those With Mental Illness Quit Smoking
Smoking · Nicotine Dependence · Mental Disorders
Primary: Acceptance of Wisconsin Tobacco Quit Line Services — 11; 6; 6 participants
Phase 2 N=49 Smoking Cessation Intervention for Thoracic Patients
Lung Cancer
Primary: Determination of the Feasibility of a Cognitive Behavioral Smoking Cessation Intervention. — 17; 32 participants
N/A N=109 Tobacco Dependence Treatment for Asian Americans
Tobacco Dependence
Primary: 12-month Abstinence — 21; 6 Participants — p=<0.01
Phase 4 N=52 Tobacco Treatment Comparison for Cancer Care
Smoking Cessation · Cancer
Primary: Biochemically Verified 7-day Point-prevalence Abstinence 26 Weeks After a Target Quit Date. — 2; 7 Participants
N/A N=14 Acceptance and Commitment Therapy for Tobacco Cessation Among Psychiatric Partial Hospital Patients
Tobacco Smoking · Psychiatric Disorder · Psychiatric Hospitalization
Primary: Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study — 17 Participants
Phase 4 N=112 Smoking Cessation Treatment for Methadone Maintenance Patients
Smoking Cessation · Substance-Related Disorders
Primary: Biochemically Verified Abstinence Verified With Expired Carbon Monoxide (CO) < 8 p.p.m. — 6; 0 participants — p=0.03
Phase 4 N=637 Identifying Optimal Smoking Cessation Intervention Components (Cessation)
Smoking · Smoking Cessation · Nicotine Dependence
Primary: Self-Reported 7-Day Point-Prevalence Abstinence — 208; 209; 201; 216 participants — p=.341
N/A N=2,896 Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Smoking Cessation
Primary: Rate of Smoking Abstinence — 33; 40; 37; 42 percentage of participants
N/A N=49 Smoking Cessation Intervention for Women Living With HIV
AIDS/HIV
Primary: Number of Participants With Abstinence — 8; 1 Participants — p=< 0.05
Phase 3 N=52 Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
Smokeless Tobacco Use
Primary: End of Treatment (Week 8) Point Prevalence Abstinence — 11; 6 participants — p=0.05
Phase 3 N=463 Smoking Cessation for American Indians
Smoking Cessation
Primary: 7-Day Point Prevalence Abstinence From Smoking for 6 Months — 49; 26; 26; 15 Participants